Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info
Editor-in-Chief: Mark H. Stoler, MD
ISSN: 1052-9551
Online ISSN: 1533-4066
Frequency: 4 issues / year
Ranking: Biochemistry & Molecular Biology 184/289
Biotechnology & Applied Microbiology 73/157
Pathology 33/78
Impact Factor: 2.257

Current Issue Highlights

Actions
View
Actions
View
Quick Poll
What is your preferred method for assessing patient lung adenocarcinomas for EGFR inhibitor therapy?
What is your preferred method for assessing patient lung adenocarcinomas for EGFR inhibitor therapy?
What is your preferred method for assessing patient lung adenocarcinomas for EGFR inhibitor therapy?
What is your preferred method for assessing patient lung adenocarcinomas for EGFR inhibitor therapy?
What is your preferred method for assessing patient lung adenocarcinomas for EGFR inhibitor therapy?
 Submit

Login


Edited and moderated by Stacey Mills, MD, Pathology Network’s Pⁿ Blog is a forum for opinions, questions, controversies, and instructive discussions across the field of pathology. Join the discussion today.

Latest Entries: